The FDA approved Zepbound (tirzepatide) in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity after research showed that the medication ...

With sleep apnea on the rise, more patients can benefit from sleep studies, and properly trained office staff can help minimize the risk of denials. It's incredibly frustrating to assess your patient, ...

A VA research team has documented the personal values that women veterans express when beginning treatment for obstructive ...

A new commentary in the Journal of Clinical Sleep Medicine examines whether dual orexin receptor antagonists can help ...

Hospitalized patients often experience sleep deprivation due to poorly designed hospital environments. Patients face challenges such as loud noises, poor control of ambient light, and frequent ...

When patients share their struggles with falling asleep or staying asleep, physicians should try to assess whether obesity is playing a role. During discussions with your patients, acknowledge those ...

Sleep problems are significantly more common among people with migraine than among those without headaches. People with ...

A promising new study found that this common sleep aid may help reduce pain in people with chronic musculoskeletal conditions, such as arthritis.